CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...